Tregoning Kathleen
- SEC CIK
- 0001830764
No open-market purchases or sales filed in the past year.
Current role at each company
- KLRA Kailera Therapeutics, Inc.See Remarksas of Jul 8, 2026
- SPRO Spero Therapeutics, Inc.Directoras of Jun 25, 2026
- CMPS COMPASS Pathways plcDirectoras of May 29, 2026
- CERE Cerevel Therapeutics Holdings, Inc.See Remarksas of Aug 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tregoning Kathleen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CERE Cerevel Therapeutics Holdings, Inc.
See Remarks1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 (view filing) | Dec 20 | 1 day | Tregoning KathleenSee Remarks | SSale | −6.29K | $41.42 | −$260.4K | −45.6%7.52K after |